JPS5883264A - Preparation of antigen for diagnosis - Google Patents
Preparation of antigen for diagnosisInfo
- Publication number
- JPS5883264A JPS5883264A JP56181023A JP18102381A JPS5883264A JP S5883264 A JPS5883264 A JP S5883264A JP 56181023 A JP56181023 A JP 56181023A JP 18102381 A JP18102381 A JP 18102381A JP S5883264 A JPS5883264 A JP S5883264A
- Authority
- JP
- Japan
- Prior art keywords
- allantois
- serous
- eggs
- incubation
- sampled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、家禽類特Kllの産卵低下症候群(Rgg
Drop 8yndrome −1976、以下rgD
s −76Jと略称する)の血清学的診断の一つである
ゲル内沈降反応の抗原の製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for treating reduced egg production syndrome (Rgg) in poultry.
Drop 8 syndrome -1976, hereinafter rgD
The present invention relates to a method for producing an antigen for in-gel precipitation reaction, which is one of the serological diagnostics for s-76J.
gDs −76はEDS −76ウイルスの感染により
生ずる伝染病で、1976年ヨーロッパで初発して以来
、徐々に世界各国に広がりつつある。これに感染した鶏
は異常卵を伴った産卵低下を起こし、その経済的被害は
多大なものになっている。そのため、本疾病の診断が必
要となり、現在では血清診断としてHI反応及びゲル内
沈降反応などが採用されている。とりわけ、lル内沈降
反応はその操作の簡便なことから、かなり広〈実施され
ている。しかしながら、そのゲル内沈降反応に使用する
抗原の調製は繁雑で、かなり高度の技術および設備を要
するという難点があった。gDs-76 is an infectious disease caused by infection with the EDS-76 virus, and since its first appearance in Europe in 1976, it has gradually spread to countries around the world. Chickens infected with this disease have a decline in egg production with abnormal eggs, resulting in significant economic damage. Therefore, it is necessary to diagnose this disease, and currently, HI reaction, gel precipitation reaction, etc. are used as serum diagnosis. Particularly, the precipitation reaction in a single container is quite widely practiced because of its simple operation. However, the preparation of antigens used in the in-gel precipitation reaction is complicated and requires fairly sophisticated techniques and equipment.
すなわち従来のyル内沈降反応に使用する抗原の調製方
法はr Avian Pathol、 J第7巻第62
9〜639頁(1978)およびJ、 B、 McF@
rran氏編r 5tudies on theムnt
ig@nic Relationshipbetwee
n an l5olation (127) from
the EggDrop Syndrome 197
6 and a Fowl AdenovlruaJに
も示されているとおり次のようである。That is, the method for preparing antigens used in the conventional intraprecipitation reaction is described in Avian Pathol, J Vol. 7, No. 62.
pp. 9-639 (1978) and J, B, McF@
Edited by Mr. RRAN 5 studies on them
ig@nicRelationshipbetweenwee
n an l5olation (127) from
the EggDrop Syndrome 197
6 and a Fowl AdenovlruaJ, as follows.
1) 8PF発育鶏卵の胎児肝細胞を採取して細胞培
養を行なう。1) Collect fetal liver cells from 8PF embryonated chicken eggs and perform cell culture.
2)培am胞[gDS−76ウイルスを接種してウィル
スを増殖し、その培養液を遠心分離し、セして上清に等
量の飽和硫安液を加えて4℃に一夜放置する。2) Cell culture [gDS-76 virus is inoculated and the virus is propagated, the culture solution is centrifuged, an equal volume of saturated ammonium sulfate solution is added to the supernatant, and the mixture is left overnight at 4°C.
3)沈澱物を遠心分離して集め、そして原培養液の14
00量の蒸溜水を加えて沈澱を溶解する。3) Collect the precipitate by centrifugation, and add 14
00 amount of distilled water is added to dissolve the precipitate.
4)それをリン酸緩衝食塩液で透析する。4) Dialyze it against phosphate buffered saline.
5)a2%の割合にホルマリンを加えてウィルスを不活
化し、そして力価を4単位Kr1il整して抗原とする
。5) Add formalin to a 2% ratio to inactivate the virus, adjust the titer to 4 units of Kr1il, and use it as an antigen.
本発明者らは従来法における難点を解決すべく研究を行
った結果、ゲル内沈降反応に使用する抗原を従来法より
簡単で且つ高度の技術および設備を要せずKll!る方
法を見い出した。本発明によるEDF3−76診断用抗
原の製造方法を以下に詳細に説明する。The present inventors conducted research to resolve the difficulties in conventional methods, and as a result, the antigen used in gel precipitation reaction is easier than conventional methods and does not require advanced technology and equipment. I found a way to The method for producing the EDF3-76 diagnostic antigen according to the present invention will be described in detail below.
gDs抗体フリーのアヒル発育卵12〜16日令KED
3−76ウイルスを接種し、5〜7日関騨卵後発育卵の
漿尿屓を採取し、希釈液を加えプールして漿尿膜細胞を
破壊しそして遠心分離し、て上清ヲ採る。ウィルス接種
部位としては漿尿腔、漿尿膜卵黄嚢内などがあるが、漿
尿腔接種がもつとも好ましい。また、靜卵後、−夜冷蔵
本K・保存してから晴尿属を採取すると採取が容易であ
る。また、希釈液にはリン酸緩衝液、生理食塩水、蒸溜
水、水などを使用する。また、漿尿膜細胞の破壊にはホ
モジナイズ、凍結融解、超音波処理などが適蟲である。gDs antibody free embryonated duck eggs 12-16 days old KED
3-76 virus was inoculated, the eggs were incubated for 5 to 7 days, and the chorioallantoic membranes of the eggs were collected, a diluent was added to the eggs, the cells were pooled, the chorioallantoic membrane cells were destroyed, the chorioallantoic membrane cells were destroyed, and the supernatant was collected by centrifugation. . Virus inoculation sites include the chorioallantoic cavity and the chorioallantoic yolk sac, but chorioallantoic inoculation is also preferred. In addition, it is easier to collect the genus Chrysanthemum after the eggs have been incubated and stored in the refrigerator overnight. In addition, a phosphate buffer, physiological saline, distilled water, water, or the like is used as a diluent. In addition, homogenization, freeze-thawing, ultrasonication, etc. are suitable for destroying chorioallantoic cells.
上記の上溝を抗原として使用してもよいが、[L2%の
割合にホルマリンを加えて不活化して使用すれば一層安
全に使用できる@まだ、使用前に抗原力価を最適一度K
a14整すれば、広範囲の抗体価の血清または卵黄につ
いて診断できる。ここで云う最適濃度とは抗原と抗血清
とをそれぞれPB8で倍々希釈し、それぞれの希釈した
抗原とそれぞれの希釈した抗血清とをすべての組み合わ
せでyル内沈降反応を行なって希釈した抗血清ともつと
もよく反応する抗原の濃度である。The above-mentioned superior groove may be used as an antigen, but it is safer to use it by adding formalin to a ratio of [L2%] to inactivate it.
If a14 is set, it is possible to diagnose serum or egg yolk samples with a wide range of antibody titers. The optimum concentration referred to here is the antiserum obtained by diluting the antigen and antiserum one-fold with PB8, and performing a precipitation reaction on all combinations of each diluted antigen and each diluted antiserum. This is the concentration of antigen that reacts well.
本発明の方法で抗原を調製すれば、従来の方法で必要な
組織培養の技術および設備が必要なく、さらに抗原のv
4製に必要な手数が省け、そして特別な無菌操作も必要
でないために、ウィルス取扱いの初心者でも簡単に抗原
を調製することが可能である。tた、本発明の方法で調
製した抗原を使用してゲル自沈゛降反応を行なった結果
は、従来方法で調製した抗原を使用した結果と実質的に
一致した0本発明方法により得られた診断用抗原を使用
してのゲル内沈降反応の操作は以下のとおりである。Preparing antigens using the method of the present invention eliminates the need for tissue culture techniques and equipment required by conventional methods, and furthermore,
4, and no special aseptic procedures are required, making it possible for even beginners in virus handling to easily prepare antigens. In addition, the results obtained by performing a gel precipitation reaction using the antigen prepared by the method of the present invention were substantially the same as the results obtained using the antigen prepared by the conventional method. The procedure for in-gel precipitation reactions using diagnostic antigens is as follows.
1)スライドグラスに1〜t2%の寒天溶液オたはアガ
ロース溶液((1116NaN1含有PBSでAm)を
寒天の厚さ約1111になるように注ぐ。1) Pour 1 to 2% agar solution or agarose solution ((Am in PBS containing 1116 NaN1) onto a slide glass so that the agar thickness is approximately 1111.
2) ’III大が固ったらパンチャーでバンチし、そ
してパンチした部分の寒天を取り除いて孔を開ける。孔
と孔との距離は約3〜4關とする。2) Once the 'III-sized pieces have hardened, punch them with a puncher, then remove the agar from the punched area and make holes. The distance between the holes is approximately 3 to 4 degrees.
6)抗原を一つの孔に入れ、そして被検血清または被検
卵黄をもう一つの孔に入れる。6) Place the antigen into one hole and the test serum or test egg yolk into the other hole.
4)湿潤箱に入れて室温で静置し、経時的にスライドグ
ラスの斜め下方より光源をあてて沈降線を観察する。4) Place it in a humid box and leave it at room temperature, and observe the sedimentation line over time by shining a light source diagonally below the slide glass.
一層なゲル内沈降反応の術式は「改訂5版細菌学実習提
要」(医科学研究所学友全編)第251−255頁の記
載を参照されたい。For the technique of further in-gel precipitation reaction, please refer to the description on pages 251-255 of "Revised 5th Edition Bacteriology Practice Summary" (Complete Edition of Alumni of the Institute of Medical Science).
実施例
ED8ウイ、A/、((JAP−1株) 108−OT
CID5Q/mを0.11の量で14日令の8PFアヒ
ル種卵1o個の漿尿腔内に接種した。4日間3′15℃
で靜卵後、1夜4℃の冷蔵庫に移して胎児を殺し、割卵
して漿尿膜を採取した。10個分の漿尿膜をプールし、
等量のPH1を加え、冷却しながら約3分間ホモジナイ
ズした。その乳剤について凍結融解を3回繰り返して行
ない、そして約5000 rpmにおいて10分関連心
分離してその上清をとった〔試料(1)〕。その上清に
ホルマリン原液を0.2−の割合で加えてウィルスを不
活化した〔試料(2)〕。賦科(1)および(2)をゲ
ル内沈降反応のための抗原とした。試料(りおよび(2
)と従来の方法で製造したゲル内沈降抗原をそれぞれ抗
血清または希釈した抗血清とゲル内沈降反応を行なった
。Example ED8 Ui, A/, ((JAP-1 stock) 108-OT
CID5Q/m was inoculated into the chorioallantoic cavity of 10 14-day-old 8PF duck eggs at a dose of 0.11. 3'15℃ for 4 days
After incubating the eggs, the fetuses were killed by placing them in a refrigerator at 4°C overnight, and the eggs were broken and the chorioallantoic membrane was collected. Pool 10 chorioallantoic membranes,
An equal amount of PH1 was added and homogenized for about 3 minutes while cooling. The emulsion was repeatedly frozen and thawed three times and centrifuged for 10 minutes at about 5000 rpm to collect the supernatant [Sample (1)]. A formalin stock solution was added to the supernatant at a ratio of 0.2 to inactivate the virus [Sample (2)]. Substrates (1) and (2) were used as antigens for in-gel precipitation reaction. Sample (ri and (2)
) and gel-precipitated antigens prepared by conventional methods were subjected to gel-precipitation reactions with antiserum or diluted antiserum, respectively.
結果は下表に掲げるとおりであり、本発明方法による抗
原は従来法のそれに充分匹敵した。The results are shown in the table below, and the antigen obtained by the method of the present invention was fully comparable to that obtained by the conventional method.
Claims (1)
候群ウィルスを接種し、靜卵後発育卵の漿尿膜を採取し
、セして秦尿属細胞を破壊し且つ遠心分離して上清を得
ることを特徴とする、産卵低下症候群の血清抗体又は卵
黄中抗体診断用ゲル内沈降抗原の調製方法。Reduced egg production syndrome antibody-free embryonated duck eggs are inoculated with reduced egg production syndrome virus, the chorioallantoic membrane of the embryonated eggs is collected, and the cells of the genus Qinuria are destroyed and the supernatant obtained by centrifugation. A method for preparing an in-gel precipitated antigen for diagnosing serum antibodies or antibodies in egg yolk for reduced egg production syndrome, characterized by:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56181023A JPS5883264A (en) | 1981-11-13 | 1981-11-13 | Preparation of antigen for diagnosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56181023A JPS5883264A (en) | 1981-11-13 | 1981-11-13 | Preparation of antigen for diagnosis |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5883264A true JPS5883264A (en) | 1983-05-19 |
JPH0132949B2 JPH0132949B2 (en) | 1989-07-11 |
Family
ID=16093405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56181023A Granted JPS5883264A (en) | 1981-11-13 | 1981-11-13 | Preparation of antigen for diagnosis |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5883264A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716476A (en) * | 2012-05-31 | 2012-10-10 | 郑州后羿制药有限公司 | Cell inactivated vaccine, egg yolk antibody injection, and preparation method of cell inactivated vaccine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5631645A (en) * | 1979-08-23 | 1981-03-31 | Fujirebio Inc | Sensitized latex for mumps virus infection diagnosis |
-
1981
- 1981-11-13 JP JP56181023A patent/JPS5883264A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5631645A (en) * | 1979-08-23 | 1981-03-31 | Fujirebio Inc | Sensitized latex for mumps virus infection diagnosis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716476A (en) * | 2012-05-31 | 2012-10-10 | 郑州后羿制药有限公司 | Cell inactivated vaccine, egg yolk antibody injection, and preparation method of cell inactivated vaccine |
Also Published As
Publication number | Publication date |
---|---|
JPH0132949B2 (en) | 1989-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tyrrell et al. | NEUTRALIZATION OF VIRUSES BY HOMOLOGOUS IMMUNE SERUM: I. Quantitative Studies on Factors Which Affect the Neutralization Reaction with Newcastle Disease, Influenza A, and Bacterial Virus, T3 | |
Rosenberger et al. | Characterization of several viruses isolated from chickens with inclusion body hepatitis and aplastic anemia | |
Calnek | Hemagglutination-inhibition antibodies against an adenovirus (virus-127) in White Pekin ducks in the United States | |
Feldman | Removal by heparin-MnCl2 of nonspecific rubella hemagglutinin serum inhibitor | |
Granoff | Noninfectious forms of Newcastle disease and influenza viruses: Studies on noninfectious virus occurring within cells that are producing fully infectious virus | |
Fadly et al. | Pathogenesis of infectious bursal disease in chickens infected with virus at various ages | |
Yanamura et al. | Studies on the virus of psittacosis cultivated in vitro | |
Metz | The agglutination of starfish sperm by fertilizin | |
Smadel et al. | Elementary bodies of vaccinia from infected chorio-allantoic membranes of developing chick embryos | |
Brown et al. | Specific precipitin reactions with the viruses of foot-and-mouth disease and vesicular stomatitis | |
JPS5883264A (en) | Preparation of antigen for diagnosis | |
Bergs et al. | A Virus (RMTDV) Derived From Chemically Induced Rat Mammary Tumors, I. Isolation and General Characteristics | |
Henle et al. | Studies on complement fixation with the viruses of influenza | |
Williamson et al. | Factors influencing the production of developmental defects in the chick embryo following infection with Newcastle disease virus | |
Hoff et al. | Isolation of a bunyamwera group arbovirus from a naturally infected caribou | |
Nakić et al. | Graft versus host reaction in parabiotic disease | |
Hanson et al. | Properties of duck hepatitis virus | |
Lazarus et al. | The Virus of Psittacosis: I. Propagation and Developmental Cycle in the Egg Membrane, Purification and Concentration | |
Choi et al. | Diagnostic utility of egg yolk for the detection of avian metapneumovirus antibodies in laying hens | |
Snoeyenbos et al. | Further studies of virus hepatitis of turkeys | |
Qualtiere et al. | A reexamination of humoral tolerance in chickens congenitally infected with an avian leukosis virus | |
Evans et al. | Pathological response of the chicken embryo to an agent which causes acute leukosis (Marek's disease) | |
Cover et al. | The distribution of the infectious synovitis agent in the tissues of artificially infected chickens | |
JP2865623B2 (en) | Preparation of hemagglutinating antigen of pestivirus | |
JP2011016845A (en) | Vaccine and diagnostic agent for iridovirus infection of fish, and method for producing those |